End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,050 KRW | -1.53% | +0.19% | -11.62% |
Dec. 29 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
Nov. 06 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
Sales 2024 * | 635B 471M | Sales 2025 * | 680B 504M | Capitalization | 448B 332M |
---|---|---|---|---|---|
Net income 2024 * | 31B 22.97M | Net income 2025 * | 44B 32.6M | EV / Sales 2024 * | 0.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
14.3
x | P/E ratio 2025 * |
10.1
x | Employees | 1,166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.72% |
1 day | -1.53% | ||
1 week | +0.19% | ||
Current month | +2.23% | ||
1 month | +1.20% | ||
3 months | -11.62% | ||
6 months | -23.57% | ||
Current year | -11.62% |
Managers | Title | Age | Since |
---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
Jin-Shik Seo
COO | Chief Operating Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Chang-Rok Seo
BRD | Director/Board Member | 62 | - |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +5.14% | - | |
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 16,050 | -1.53% | 141,929 |
24-03-27 | 16,300 | -1.45% | 134,080 |
24-03-26 | 16,540 | -1.90% | 157,484 |
24-03-25 | 16,860 | -0.06% | 243,686 |
24-03-22 | 16,870 | +5.31% | 522,939 |
End-of-day quote Korea S.E., March 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.62% | 337M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |